Trial Profile
Confirmatory study in adult patients with atopic dermatitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Pimecrolimus (Primary)
- Indications Atopic dermatitis
- Focus Registrational; Therapeutic Use
- Sponsors Novartis
- 23 May 2016 New trial record